{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:13:18Z","timestamp":1790982798146,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.dld.2011.06.016","type":"journal-article","created":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T19:15:56Z","timestamp":1312226156000},"page":"905-911","source":"Crossref","is-referenced-by-count":11,"title":["Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma"],"prefix":"10.1016","volume":"43","author":[{"given":"Mathieu","family":"Boulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ciboulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bonnetain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Minello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Gagnaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00f4me","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bedenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Cercueil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Chauffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Louis","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2011.06.016_bib0005","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2011.06.016_bib0010","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality and survival trends in the United States from 1975 to 2005","volume":"27","author":"Altekruse","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2011.06.016_bib0015","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(09)60381-0","article-title":"Major achievements in hepatocellular carcinoma","volume":"37","author":"Bruix","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2011.06.016_bib0020","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.dld.2011.06.016_bib0025","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomised controlled trial of transarterial lipiodol chemoembolisation for unresectable hepatocellular carcinoma","volume":"35","author":"Lo Cm","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2011.06.016_bib0030","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolization or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2011.06.016_bib0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","article-title":"Transarterial chemoembolisation for unresectable hepatocellular carcinoma: meta-analysis of randomised controlled trials","volume":"224","author":"Camma","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2011.06.016_bib0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomised trials for unresectable hepatocellular carcinoma: chemoembolisation improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2011.06.016_bib0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","article-title":"Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomised studies","volume":"30","author":"Marelli","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.dld.2011.06.016_bib0050","first-page":"559","article-title":"Overexpression of multidrug resistance genes MDR1 and Cmoat in human hepatocellular carcinoma and hepatoblastoma cell lines","volume":"15","author":"Minemura","year":"1999","journal-title":"Int J Oncol"},{"key":"10.1016\/j.dld.2011.06.016_bib0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11596-007-0217-8","article-title":"The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance","volume":"27","author":"Li","year":"2007","journal-title":"J Huazhong Univ Technolog Med Sci"},{"key":"10.1016\/j.dld.2011.06.016_bib0060","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/86.9.700","article-title":"MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines","volume":"86","author":"Park","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.dld.2011.06.016_bib0065","first-page":"325","article-title":"MDR (Multidrug resistance) in clinical-therapeutic implications","volume":"154","author":"Petraccia","year":"2003","journal-title":"Clin Ter"},{"key":"10.1016\/j.dld.2011.06.016_bib0070","first-page":"825","article-title":"Amiodarone-induced enhancement of doxorubicin and 4\u2032-deoxydoxorubicin cytotoxicity to rat colon cancer cells in vitro and in vivo","volume":"46","author":"Chauffert","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.dld.2011.06.016_bib0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00001813-200111000-00003","article-title":"Increased cytotoxicity and stability of Lipiodol-pirarubicin emulsion compared to classical doxorubicin-Lipiodol: potential advantage for chemoembolisation of unresectable hepatocellular carcinoma","volume":"12","author":"Favoulet","year":"2001","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.dld.2011.06.016_bib0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-3659(97)00127-2","article-title":"Stable lipiodolized emulsions for hepatoma targeting and treatment by transcatheter arterial embolization","volume":"50","author":"Yi","year":"1998","journal-title":"J Control Release"},{"key":"10.1016\/j.dld.2011.06.016_bib0085","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2011.06.016_bib0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1148\/radiographics.19.2.g99mr08399","article-title":"Chemoembolisation of hepatic neoplasms: safety, complications, and when to worry","volume":"19","author":"Gates","year":"1999","journal-title":"Radiographics"},{"key":"10.1016\/j.dld.2011.06.016_bib0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liv Dis"},{"key":"10.1016\/j.dld.2011.06.016_bib0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1289\/ehp.793231","article-title":"Clinical trials in cancer research","volume":"32","author":"Gehan","year":"1979","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.dld.2011.06.016_bib0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1968","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.dld.2011.06.016_bib0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/COC.0b013e3181845529","article-title":"Pilot study of transarterial chemoembolisation with pirarubicin and amiodarone for unresectable hepatocellular carcinoma","volume":"32","author":"Guiu","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.dld.2011.06.016_bib0115","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0399-8320(04)95221-9","article-title":"Sustained clinical response of large hepatocellular carcinoma after chemoembolisation with pirarubicin, amiodarone and lipiodol","volume":"28","author":"Cercueil","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.dld.2011.06.016_bib0120","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ijc.2910480422","article-title":"In vitro and in vivo modulation of multi-drug resistance with amiodarone","volume":"48","author":"Van der Graaf","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dld.2011.06.016_bib0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/bjc.1987.167","article-title":"Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cells","volume":"56","author":"Chauffert","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2011.06.016_bib0130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1097-0142(19920801)70:3<585::AID-CNCR2820700308>3.0.CO;2-#","article-title":"Chemoembolisation of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin","volume":"70","author":"Raoul","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2011.06.016_bib0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","article-title":"Chemoembolisation of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics","volume":"46","author":"Varela","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2011.06.016_bib0140","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jhep.2009.09.004","article-title":"Transarterial chemotherapy alone versus transarterial chemoembolisation for hepatocellular carcinoma: a randomised phase III trial","volume":"51","author":"Okusaka","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2011.06.016_bib0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","article-title":"Prospective cohort study of transarterial chemoembolisation for unresectable hepatocellular carcinoma in 8510 patients","volume":"131","author":"Takayasu","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2011.06.016_bib0150","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ctrv.2010.07.006","article-title":"Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization","volume":"37","author":"Raoul","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.dld.2011.06.016_bib0155","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199505113321903","article-title":"A comparison of lipiodol chemoembolisation and conservative treatment for unresectable hepatocellular carcinoma","volume":"332","author":"Groupe d\u2019Etude et de Traitement du Carcinome H\u00e9patocellulaire","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2011.06.016_bib0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(98)80187-6","article-title":"Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolisation: a multicenter randomised trial","volume":"29","author":"Pelletier","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2011.06.016_bib0165","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejca.2008.01.004","article-title":"Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive 9402)","volume":"44","author":"Doffo\u00ebl","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2011.06.016_bib0170","article-title":"Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects","author":"Shiga","year":"2010","journal-title":"Heart Vessels"},{"key":"10.1016\/j.dld.2011.06.016_bib0175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.annemergmed.2010.06.001","article-title":"Intravenous lipid emulsion sequesters amiodarone in plasma and eliminates its hypotensive action in pigs","volume":"56","author":"Niiya","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.dld.2011.06.016_bib0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.dld.2011.06.016_bib0185","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/lt.21109","article-title":"Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case\u2013control study","volume":"13","author":"Dharancy","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2011.06.016_bib0190","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/hep.24246","article-title":"Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5cm) hepatocellular carcinomas","volume":"53","author":"Golfieri","year":"2011","journal-title":"Hepatology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865811002301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865811002301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T21:28:15Z","timestamp":1543613295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865811002301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1590865811002301"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2011.06.016","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}